載入...
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
BACKGROUND & AIMS: Adverse events (AEs) including reactivation of herpes zoster (HZ) and venous thromboembolism (VTE) have been reported from clinical trials of tofacitinib in ulcerative colitis (UC). We investigated the incidence rates of AEs in a real-world study of UC patients given tofacitin...
Na minha lista:
| 發表在: | Clin Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779667/ https://ncbi.nlm.nih.gov/pubmed/32629130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2020.06.050 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|